MSTN and obesity disorder: MSTN inhibition induce a reduction of fat in obesity and osteoporosis and has also been suggested for other diseases in which cachexia is present such as cancer, acquired immune deficiency syndrome (AIDS), obstructive chronic pulmonary disease, and renal failure [174].